Firm Record

Promise Pharmacy, LLC findings history

16 findings from 2 inspection documents published by regulators. Each row below says what its date means.

US FDA 2019-04-30 ~ 2019-05-13 2 documents 16 findings

Areas cited

Other quality systemAseptic processing and sterility assuranceEquipment and facilityLaboratory and QC controlsStability and storageQuality unit oversight

Published inspection documents

2019-05-13 US FDA 8 findingsOther quality system · Stability and storage · Quality unit oversight · Aseptic processing and sterility assurance · Laboratory and QC controls · Equipment and facility Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess. 2019-04-30 US FDA 8 findingsQuality unit oversight · Other quality system · Equipment and facility · Stability and storage · Laboratory and QC controls · Aseptic processing and sterility assurance The quality control unit lacks responsibility to approve and reject all procedures or specifications impacting on the identity, strength, quality and purity of drug products.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of Promise Pharmacy, LLC — including inspection classifications Browse by document Go to Findings search